
LANXESS Aktiengesellschaft (LNXSY) Q2 2026 Earnings Call Transcript
LANXESS Aktiengesellschaft (LNXSY) Q2 2026 Earnings Call Transcript
Follow the latest financial and economic news, market updates, reports, and analysis on PipVero.

LANXESS Aktiengesellschaft (LNXSY) Q2 2026 Earnings Call Transcript

ANI Pharmaceuticals, Inc. (ANIP) Q2 2026 Earnings Call Transcript

New York, New York--(Newsfile Corp. - August 7, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Embecta Corp. ("Embecta" or the "Company") (NASDAQ: EMBC) on behalf of investors that purchased or otherwise acquired Embecta securities between November 25, 2025 and May 4, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Embecta and have suffered losses, you may CLICK HERE to contact us.

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in EquipmentShare.com Inc. ("EquipmentShare" or the "Company") (NASDAQ: EQPT) of a class action securities lawsuit.

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Erasca, Inc. ("Erasca" or the "Company") (NASDAQ: ERAS) of a class action securities lawsuit.

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 25, 2026 to file lead plaintiff applications in a securities class action lawsuit against Futu Holdings Limited ("Futu" or the "Company") (NASDAQ: FUTU), if they purchased or otherwise acquired the Company's securities between May 24, 2023 and May 27, 2026, inclusive (the "Class Period").

Healthpeak Properties remains a Buy, supported by strong earnings, attractive dividend, and an ongoing portfolio pivot despite macro headwinds. DOC delivered a robust Q2, beating FFO and revenue estimates, increasing guidance, and executing $1 billion in asset sales to strengthen liquidity. Valuation remains compelling, with intrinsic value estimated above current levels even under conservative estimates, supported by conservative AFFO growth and a high discount rate.

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 28, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hub Group, Inc. ("Hub" or the "Company") (NASDAQ: HUBG), if they purchased or otherwise acquired the Company's securities between April 28, 2023, and May 11, 2026, inclusive (the "Class Period").

Burger King is once again the second-largest burger chain in the U.S. by systemwide sales. The chain's successful turnaround has helped it unseat Wendy's from the number two spot.

Boston, Massachusetts--(Newsfile Corp. - August 7, 2026) - Block & Leviton is investigating T1 Energy (NYSE: TE) for potential securities law violations. Investors who have lost money in their T1 Energy investment should contact the firm to learn more about how they might recover those losses.

Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital tool in the prevention of New World screwworm infestations. Elanco also offers producers Negasunt® Powder (coumaphos, propoxur, and sulfanilamide topical powder) and Tanidil®, which received emergency authorizations earlier this year, as well as EPA-registered Catron™ IV.

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 7, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA) of a class action securities lawsuit.

LITE heads into fiscal Q4 earnings with strong AI optics demand and a 1.6T transceiver ramp, though supply constraints could limit upside.

OCGN posts a wider Q2 loss as R&D spending climbs, while advancing late-stage gene therapy programs and extending its cash runway into 2028.

AMD's post-earnings dip highlights near-term PC and gaming weakness, but surging Data Center demand and AI deployments support long-term growth prospects.